Vivos Therapeutics Schedules Release of Third Quarter 2024 Financial Results and Conference Call
Portfolio Pulse from
Vivos Therapeutics, Inc. (NASDAQ: VVOS) will release its Q3 2024 financial results on November 14, 2024, after market close. The company specializes in treatments for sleep-related breathing disorders.
November 13, 2024 | 10:15 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Vivos Therapeutics is set to release its Q3 2024 financial results, which could provide insights into the company's performance and future prospects in the sleep-related breathing disorder market.
The announcement of financial results is a routine event that can influence stock prices depending on the performance reported. However, without specific details on expected performance, the short-term impact is neutral.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100